IRIS
BRUZZI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.870
AS - Asia 184
NA - Nord America 33
SA - Sud America 31
AF - Africa 7
Totale 4.125
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.866
SG - Singapore 86
VN - Vietnam 47
CN - Cina 41
US - Stati Uniti d'America 25
BR - Brasile 16
AR - Argentina 6
MX - Messico 6
ID - Indonesia 5
HK - Hong Kong 4
EC - Ecuador 3
ZA - Sudafrica 3
CO - Colombia 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
ES - Italia 1
GB - Regno Unito 1
HN - Honduras 1
KE - Kenya 1
LY - Libia 1
MR - Mauritania 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.125
Salva come PNG Salva come JPEG
Città #
Genova 2.028
Genoa 1.094
Rapallo 433
Vado Ligure 299
Singapore 32
Ho Chi Minh City 18
Beijing 17
Bordighera 12
Hanoi 12
Ashburn 7
Da Nang 4
Hong Kong 4
Mexico City 4
Agawam 2
Dallas 2
Haiphong 2
Huntington 2
Hải Dương 2
Abidjan 1
Annapolis 1
Apache Junction 1
Arafat 1
Benghazi 1
Blumenau 1
Bogotá 1
Boksburg 1
Buenos Aires 1
Bắc Ninh 1
Can Tho 1
Cape Town 1
Caracas 1
Carapicuíba 1
Chicago 1
Cochabamba 1
Cuiabá 1
Curitiba 1
Denpasar 1
Denver 1
Diadema 1
Frecheirinha 1
Frías 1
Guayaquil 1
Hurlingham 1
Hưng Yên 1
Iporã 1
Iztapalapa 1
Jakarta 1
Johannesburg 1
Joinville 1
Las Heras 1
Leskovac 1
León 1
Lomas de Zamora 1
Los Angeles 1
Machala 1
Makassar 1
Manama 1
Medellín 1
Montevideo 1
Nairobi 1
Nanjing 1
New York 1
Ninh Bình 1
Pedro Afonso 1
Petrich 1
Poplar 1
Porto Alegre 1
Quito 1
Recife 1
Salvador 1
Samarinda 1
San Justo 1
San Pedro Sula 1
Santa Clara 1
Santa María 1
Semarang 1
Sorocaba 1
São Joaquim de Bicas 1
São Paulo 1
Vinh 1
Várzea Paulista 1
Xinxiang 1
Yên Bái 1
Zhongshan 1
Totale 4.040
Salva come PNG Salva come JPEG
Nome #
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 219
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 210
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 176
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits. 171
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 168
Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer 163
BCR-ABL nuclear entrapment kills human CML cells: ex-vivo study on 35 patients with the combination of Imatynib Mesylate and Leptomycin B 159
Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity. 159
Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes 153
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 151
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 149
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score. 147
A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes 144
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials 142
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 140
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 139
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials 138
A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility 137
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole 137
Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study 136
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 x 2 factorial, randomised phase 3 trial 131
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 124
Self-perceived normality in defecation habits 121
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments 111
Identification and validation of a new set of five genes for prediction of risk in early breast cancer. 109
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group 106
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis 91
Management of Childhood-onset Craniopharyngioma in Italy: A Multicenter, 7-Year Follow-up Study of 145 Patients 81
Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: Systematic review assessing criteria used to define remission and recurrence 73
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700) 73
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 39
Phase IIA study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point 27
Totale 4.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.148
article - articoli 15.148
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 25 11 40 17 46 22 21
2021/2022373 20 17 28 39 13 33 15 82 29 35 17 45
2022/2023497 36 52 7 47 69 70 2 62 79 3 63 7
2023/2024218 9 30 3 33 21 18 22 17 8 9 14 34
2024/2025780 30 48 28 56 88 76 50 160 24 38 95 87
2025/2026605 186 13 92 85 211 18 0 0 0 0 0 0
Totale 4.224